Welcome to the Villeneuve Lab

The Villeneuve Lab is interested in how the brain ages with a specific focus on the factors that modify the association between brain lesions and cognitive performances. Our research is motivated by the fact that more than 25% of older adults are considered cognitively normal despite the presence of beta-amyloid in their brain, a hallmark of Alzheimer’s disease. This fact suggests that other factors interact with beta-amyloid to trigger the expression of cognitive deficits in Alzheimer’s disease. It also suggests that actions can be taken to prevent or postpone the expression of disease-related symptoms. The main focus of The Villeneuve Lab’s research is therefore to examine the factors that protect (or worse) the development of cognitive deficits in age-related neurodegenerative diseases. We use a multi-tier approach that includes molecular PET imaging, MRI imaging, neuropsychological testing, and genetics.

Visit our research page to learn more about our ongoing projects.

 

Recent News

 

Human Amyloid Imaging Conference 2018
17-19 Jan 2018

Dr. Villeneuve, along with Julie Gonneaud and Alexa Pichet Binette attended this year’s HAI conference in Miami to present some of their recent work. Julie gave a talk comparing sporadic AD and autosomal dominant AD, and Alexa presented her poster at the conference. [Photos]

 

New Article by Villeneuve Lab alumnus Sander Verfaillie
14 Dec 2017

A new article by Sander Verfaillie, “Subjective cognitive decline is associated with altered default mode network connectivity in individuals with a family history of Alzheimer’s Disease” published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging feature research on the subjective cognitive decline, brain connectivity pattern and family history of dementia.

Happy New Years! Our Lab Christmas Party 2017
7 Dec 2017

The Villeneuve Lab wishes everyone a happy new year! Photos

Human Amyloid Imaging Conference
2 Dec 2017

Congrats to Julie on receiving Human Amyloid Imaging conference travel fellowship to attend the conference that will be held on January 17-19, 2018 in Miami, FL.